New shot aims to ease pain for days after bunion surgery

NCT ID NCT07574385

Recruiting now Symptom relief Sponsor: Rebel Medicine Inc Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new long-acting painkiller called ALX006 for pain after bunion surgery. About 60 adults will receive a single nerve block shot of either ALX006 or a standard painkiller. The goal is to see if ALX006 provides longer pain relief with fewer side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ALX006 (extended-release bupivacaine)
What this could lead to: If it works, this could provide longer-lasting pain relief after foot surgery with fewer injections.
What could go wrong: This is an early Phase 2 trial with only 60 people, so results may not apply widely. The drug may cause side effects or not work better than standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BUNIONECTOMY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agnosia Hallux Valgus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BUNIONECTOMY HALLUX VALGUS

Contacts and locations

Locations

CenExel Salt Lake City
RECRUITING

Millcreek, Utah, 84107, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.